Myoclonic dystonia;Les dystonies myocloniques

Revue Neurologique

Volumn 159, Issue 10 I, 2003, Pages 892-899

  Cassim, F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; EPSILON SARCOGLYCAN; SARCOGLYCAN; UNCLASSIFIED DRUG;

BENIGN HEREDITARY CHOREA; BRAIN DEPTH STIMULATION; CHOREA; CHROMOSOME 14Q; CHROMOSOME 7Q; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DYSTONIA; ESSENTIAL MYOCLONUS; FAMILIAL DISEASE; GENE LOCATION; GENE MAPPING; GENE MUTATION; HEREDITY; HUMAN; MYOCLONIC DYSTONIA; OBSESSIVE COMPULSIVE DISORDER; REVIEW; TORTICOLLIS;

ALCOHOLISM; CHOREATIC DISORDERS; DYSTONIA; HUMANS; MYOCLONUS;

EID: 0141645236     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. ANGELINI C, FANIN M, FREDA M, DUGGAN DJ, SICILIANO G, HOFFMAN EP. (1999). The clinical sarcoglycanopathies. Neurology, 52:176-179.
2. ASMUS F, ZIMPRICH A, TEZENAS DU MONTCEL S et al. (2002). Myoclonus-dystonia syndrome: Epsilon-sarcoglycan mutations and phenotype. Ann Neurol, 52: 489-492.
3. BREEDVELD GJ, PERCY AK, MACDONALD ME et al. (2002). Clinical and genetic heterogeneity in benign hereditary chorea. Neurology, 59: 579-584.
4. CASSIM F, DERAMBURE P, DEFEBVRE L, BOURRIEZ JL, DESTÉE A, GUIEU JD. (2000). Exploration neurophysiologique des tremblements. Neurophysiol Clin, 30: 81-96.
5. DE MEDINA A, BIASINI O, RIVERA A, SAMPERA A. (1986). Nifedipine and myoclonic dystonia. Ann Intern Med, 104: 125.
6. DE VRIES BBA, ARTS WFM, BREEDVELD GJ et al. (2000). Benign hereditary chorea of early onset maps to chromosome 14q. Am J Hum Genet, 66: 136-144.
7. DEFEBVRE L, CASSIM F. (2003). Neurophysiologie des syndromes parkinsoniens. Rev Neurol, 159: 3S62-3S74.
8. DOHENY DO, BRIN MF, MORRISON CE et al. (2002a). Phenotypic features of myoclonus-dystonia in three kindreds. Neurology, 59: 1187-1196.
9. DOHENY D, DANISI F, SMITH C et al. (2002b). Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology, 59: 1244-1246.
10. DÜRR A, TASSIN J, VIDAILHET M et al. (2000). D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann Neurol, 48:127-128.
11. FAHN S, BRESSMAN S, MARSDEN CD. (1998). Classification of dystonia. Adv Neurol, 78: 1-10.
12. FAHN S, SJAASTAD O. (1991). Hereditary essential myoclonus in a large Norwegian family. Mov Disord, 6: 237-247.
13. FONCKE EMJ, KLEIN C, KOELMAN JHTM et al. (2003). Hereditary myoclonus-dystonia associated with epilepsy. Neurology, 60: 1988-1990.
14. FURUKAWA Y, RAJPUT AH. (2002). Inherited myoclonus-dystonia: how many causative genes and clinical phenotypes? Neurology, 59: 1130-1131.
15. GASSER T. (1998). Inherited myoclonus-dystonia syndrome. Adv Neurol, 78: 325-334.
16. GASSER T, BEREZNAI B, MULLER B, PRUSZAK-SEEL R, DAMRICH R, DEUSCHL G, OERTEL WH. (1996). Linkage studies in alcohol-responsive myoclonic dystonia. Mov Disord, 11: 363-370.
17. GRABOWSKI M, ZIMPRICH A, LORENZ-DEPIEREUX B et al. (2003). The ε-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet, 11: 138-144.
18. GRIMES DA, BULMAN D, GEORGE-HYSLOP PS, LANG AE. (2001). Inherited myoclonus-dystDnia: evidence supporting genetic heterogeneity. Mov Disord, 16: 106-110.
19. GRIMES DA, HAN F, LANG AE, ST GEORGE-HYSSOP P, RACACHO L, BULMAN DE. (2002). A novel locus for inherited myoclonus-dystonia on 18p11. Neurology, 59: 1183-1186.
20. GROEN RJ, LAMBOOY N, TAVY DL. (1989). Myoclonic dystonia: effective treatment by cervical cord stimulation. A case report. Surg Neurol, 32: 72-74.
21. HAERER AF, CURRIER RD, JACKSON JF. (1966). Hereditary non-progressive chorea of early onset. Neurology, 16: 307.
22. HICKS CB, ABRAHAM K. (1985). Verapamil and myoclonic dystonia. Ann Intern Med, 103: 154.
23. HJERMIND LE, WERDELIN LM, EIBERG H, KRAG-OLSEN B, DUPONT E, SORENSEN SA. (2003). A novel mutation in the Epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome. Neurology, 60: 1536-1539.
24. KLEIN C, OZELIUS LJ. (2002). Dystonia: clinical features, genetics, and treatment. Curr Opin Neurol, 15: 491-497.
25. KLEIN C, BRIN MF, KRAMER P et al. (1999). Association of a missense change in the D2 dopamine receptor in myoclonus dystonia. Proc Natl Acad Sci USA, 96: 5173-5176.
26. KLEIN C, GURVICH N, SENA-ESTEVES M et al. (2000a). Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann Neurol, 47: 369-373.
27. KLEIN C, SCHILLING K, SAUNDERS-PULLMAN RJ et al. (2000b). A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet, 67: 1314-1319.
28. KLEIN C, LIU L, DOHENY D, KOCK N et al. (2002). Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann Neurol, 52: 675-679.
29. KORTEN JJ, NOTERMANS SLH, FRENKEN CWGM, GABREELS FJM, JOOSTEN EMG. (1974). Familial essential myoclonus. Brain, 97: 131-138.
30. KRYSTKOWIAK P, MARTINAT P, DEFEBVRE L, PRUVO JP, LEYS D, DESTÉE A. (1998). Dystonia after striatopallidal and thalamic stroke. J Neurol Neurosurg Psychiatry, 65: 703-708.
31. KURLAN R, BEHR J, MEDVED L, SHOULSON I. (1988). Myoclonus and dystonia: a family study. Adv Neurol, 50: 385-389.
32. KYLLERMAN M, FORSGREN L, SANNER G, HOLMGREN G, WAHLSTROM J, DRUGGE U. (1990). Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord, 5: 270-279.
33. LEHÉRICY S, VIDAILHET M, DORMONT D et al. (1996). Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study. Arch Neurol, 53:241-250.
34. LEHERICY S, GRAND S, POLLAK P et al. (2001). Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology, 57: 1055-1066.
35. LEUNG JC, KLEIN C, FRIEDMAN J et al. (2001). Novel mutation in the TorlA (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics, 3: 133-143.
36. LEUZZI V, CARDUCCI C, CARDUCCI C, CARDONA F, ARTIOLA C, ANTONOZZI I. (2002). Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology, 59: 1241-1243.
37. LINDENMULDER FG. (1933). Familial myoclonus occurring in three successive generations. J Nerv Ment Dis, 77: 489-491.
38. LIU X, GRIFFIN IC, PARKIN SG et al. (2002). Involvement of the medial pallidum in focal myoclonic dystonia: A clinical and neurophysiological case study. Mov Disord, 17: 346-353.
39. MAHANT N, CORDATO DJ, FUNG VS. (2003). Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: Clinical and neurophysiological features. Mov Disord, 18: 452-455.
40. MAHLOUDJI M, PIKIELNY RT. (1967). Hereditary essential myoclonus. Brain, 90: 669-674.
41. MARECHAL L, RAUX G, DUMANCHIN C et al. (2003). Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet, 119B: 114-117.
42. MULLER B, HEDRICH K, KOCK N et al. (2002). Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet, 71: 1303-1311.
43. NEMETH AH. (2002). The genetics of primary dystonias and related disorders. Brain, 125: 695-721.
44. NYGAARD TG, RAYMOND D, CHEN C et al. (1999). Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol, 46:794-798.
45. OBESO JA, ROTHWELL JC, LANG AE, MARSDEN CD. (1983). Myoclonic dystonia. Neurology, 33: 825-830.
46. PRIORI A, BERTOLASI L, PESENTI A, CAPPELLARI A, BARBIERI S. (2000). Gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia. Neurology, 54: 1706.
47. QUINN NP. (1996). Essential myoclonus and myoclonic dystonia. Mov Disord, 11: 119-124.
48. QUINN NP, MARSDEN CD. (1984). Dominantly inherited myoclonic dystonia with dramatic response to alcohol [abstract]. Neurology, 34:236.
49. QUINN NP, ROTHWELL JC, THOMPSON PD, MARSDEN CD. (1988). Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol, 50: 391-401.
50. SAUNDERS-PULLMAN R, OZELIUS L, BRESSMAN SB. (2002a). Inherited myoclonus-dystonia. Adv Neurol, 89: 185-191.
51. SAUNDERS-PULLMAN R, SHRIBERG J et al. (2002b). Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology, 58: 242-245.
52. SCHRAG A, QUINN NP, BHATIA KP, MARSDEN CD. (2000). Benign hereditary chorea - entity or syndrome? Mov Disord, 15: 280-288.
53. THOMPSON PD, DAY BL, ROTHWELL JC, BROWN P, BRITTON TC, MARSOLEN CD. (1994). The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus Brain, 117: 1197-1207.
54. TROTTENBERG T, MEISSNER W, KABUS C et al. (2001). Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. Mov Disord, 16: 769-771.
55. VANEK Z, JANKOVIC J. (2001). Dystonia in corticobasal degeneration. Mov Disord, 16: 252-257.
56. VIDAILHET M, TASSIN J, DURIF F et al. (2001). A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology, 56: 1213-1216.
57. ZIMPRICH A, GRABOWSKI M, ASMUS F et al. (2001). Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet, 29: 66-69.